about
Increasing GLP-1 Circulating Levels by Bariatric Surgery or by GLP-1 Receptor Agonists Therapy: Why Are the Clinical Consequences so Different?Is GLP-1 a hormone: Whether and When?Oral delivery of glucagon-like peptide-1 and analogs: alternatives for diabetes control?Recognizing and treating secondary osteoporosisPhase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer.Progressive change of intra-islet GLP-1 production during diabetes developmentLixisenatide resensitizes the insulin-secretory response to intravenous glucose challenge in people with type 2 diabetes--a study in both people with type 2 diabetes and healthy subjects.Additive effects of miglitol and anagliptin on insulin-treated type 2 diabetes mellitus: a case study.Phase I study of pasireotide (SOM 230) and everolimus (RAD001) in advanced neuroendocrine tumorsA pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markersMathematical Modeling of Interacting Glucose-Sensing Mechanisms and Electrical Activity Underlying Glucagon-Like Peptide 1 SecretionReceptor oligomerization in family B1 of G-protein-coupled receptors: focus on BRET investigations and the link between GPCR oligomerization and binding cooperativity.GPR142 Controls Tryptophan-Induced Insulin and Incretin Hormone Secretion to Improve Glucose MetabolismA computational systems analysis of factors regulating α cell glucagon secretion.GLP-1 receptor agonists: Nonglycemic clinical effects in weight loss and beyond.Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial.Mechanisms Regulating Insulin Response to Intragastric Glucose in Lean and Non-Diabetic Obese Subjects: A Randomized, Double-Blind, Parallel-Group Trial.Upregulated insulin secretion in insulin-resistant mice: evidence of increased islet GLP1 receptor levels and GPR119-activated GLP1 secretion.Effects of intraportal exenatide on hepatic glucose metabolism in the conscious dog.Linagliptin as add-on therapy to insulin for patients with type 2 diabetesPolymorphisms of the KCNQ1 gene are associated with the therapeutic responses of sulfonylureas in Chinese patients with type 2 diabetes.Recent patents of dipeptidyl peptidase IV inhibitors.A review of gliptins in 2011.The alpha-cell as target for type 2 diabetes therapy.Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings.Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin.Glucagon and type 2 diabetes: the return of the alpha cell.DPP-4 inhibitors: focus on safety.Dual-hormone treatment with insulin and glucagon in patients with type 1 diabetes.Glucagon-like polypeptide agonists in type 2 diabetes mellitus: efficacy and tolerability, a balance.Differential Effects of Linagliptin on the Function of Human Islets Isolated from Non-diabetic and Diabetic Donors.Insulin resistance, role of metformin and other non-insulin therapies in pediatric type 1 diabetes.G protein-coupled receptors as new therapeutic targets for type 2 diabetes.Luseogliflozin improves liver fat deposition compared to metformin in type 2 diabetes patients with non-alcoholic fatty liver disease: A prospective randomized controlled pilot study.Genetic markers predicting sulphonylurea treatment outcomes in type 2 diabetes patients: current evidence and challenges for clinical implementation.Oral 2-oleyl glyceryl ether improves glucose tolerance in mice through the GPR119 receptor.The New Biology and Pharmacology of Glucagon.Albiglutide: a unique GLP-1 receptor agonist.Diabetes-induced mechanophysiological changes in the small intestine and colon.The effects of phenylalanine on exercise-induced fat oxidation: a preliminary, double-blind, placebo-controlled, crossover trial.
P2860
Q26744254-711EC907-B848-4162-85AA-E9B7C4ACAA5FQ26749196-6799E446-43C9-451F-91CA-68351B5C43A5Q27023585-CBB77D37-CADD-4A25-95C5-5399DDE24C60Q28270738-1C0C030E-B77C-48F9-8E3C-74AD9241BCEEQ33424008-115F2177-039F-47A3-866D-4414D4257423Q34021138-EF2A1CFA-B71D-4DB6-8441-A1C1A757A36EQ34543003-A15F447A-54DB-496E-A190-54D6C76D4D07Q34990233-5EEF21CC-8EA2-4B28-B49D-C6739B46B99CQ35747137-D8BA20EB-1E7D-46A3-B0C4-5E0B35467244Q35838203-F21A1A49-AAE0-41B3-947B-241B6C383EB3Q35858749-866BD150-78D5-4557-94AD-4E1E6E828005Q35971449-2552F3E5-5DB4-4CE3-90E2-6254491CF685Q36056936-68D0B088-0696-4025-A15E-A990FB1E6D00Q36394674-CE662F81-6B8A-4A27-9C87-568C03DD7F37Q36406821-214DF24E-E0ED-4195-B2FA-826576DF05C0Q36547683-5160AD4C-ECA8-4ADB-9D50-EED06AC54489Q36653124-1B991332-8F06-41F9-A1DF-F52A4E8F70A6Q36924521-55D09985-389E-427D-B6D6-20F16F3F8EAAQ37051107-713FCC3A-859C-4B86-82E4-E13B28AEE083Q37281205-D445C163-3194-42A5-80BE-2EBF22D70AB4Q37571899-0893CFA8-DCBB-4FE7-9FBF-3A771D8C4C13Q37948110-92DE46F8-F9AE-404E-BEE5-B0150698CBDCQ37965612-B71A124C-52E5-4F31-8FAD-DD3C81D4B00FQ37977335-4FFEFBCE-D73E-4534-86F5-D4A8EF74F704Q38014516-1BF158D3-148B-49C5-B4A0-E79F1E95EEFFQ38083641-7862ACD1-4A4B-4CD9-8707-CB3A377A7A82Q38262673-BE6A892B-20B4-4F54-8641-54DF3C2C1ABDQ38285608-795C6767-46BB-4DED-B4D8-708B75DF5AE1Q38297682-EE420638-2A42-4704-99B0-A86537F40F01Q38542098-FEA4FA21-3D52-4B70-85CB-F8937F0052C6Q38628168-90FA2B13-C7F5-41E5-A40F-569366E885C5Q38642435-B2001CC7-1932-478E-8FC4-8AEA3EBAEB2BQ38667727-4E3E511F-BA4F-4ADB-ACA6-85A9266DC90BQ38674014-6598079E-998F-4B6E-B5BD-8D670FAD7888Q38711541-6FA0AB2B-3C2B-4F1F-8B29-379AAB5A6031Q38764638-5CBE70ED-6553-4E2C-A7C7-B3C8B0C435CBQ38919742-A4F1154A-F394-438C-A81B-4F2CAA85585AQ38966029-98FAF547-1432-400E-8934-BC3AA1DAF688Q39427195-1C402CE7-765F-4AE6-A898-944D29B6DD04Q41173001-14543EF3-8865-48BC-9CD1-4E61C9F1F5C0
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Regulation of glucagon secretion by incretins.
@en
Regulation of glucagon secretion by incretins.
@nl
type
label
Regulation of glucagon secretion by incretins.
@en
Regulation of glucagon secretion by incretins.
@nl
prefLabel
Regulation of glucagon secretion by incretins.
@en
Regulation of glucagon secretion by incretins.
@nl
P2093
P2860
P50
P1476
Regulation of glucagon secretion by incretins.
@en
P2093
M Christensen
U Kielgast
P2860
P356
10.1111/J.1463-1326.2011.01452.X
P478
13 Suppl 1
P577
2011-10-01T00:00:00Z